PMID: 8946019Nov 4, 1996Paper

Altered G1 checkpoint control determines adaptive survival responses to ionizing radiation

Mutation Research
D A BoothmanM Wang

Abstract

Adaptive survival responses (ASRs) are observed when cells become more resistant to a high dose of a cytotoxic agent after repeated low dose exposures to that agent or another genotoxic agent. Confluent (G0/G1) human normal (GM2936B, GM2937A, AG2603, IMR-90), cancer-prone (XPV2359), and neoplastic (U1-Mel, HEp-2, HTB-152) cells were primed with repeated low doses of X-rays (ranging from 0.05-10 cGy/day for 4 days), then challenged with a high dose (290-450 cGy) on day 5. U1-Mel and HEp-2 cells showed greater than 2-fold transient survival enhancement when primed with 1-10 cGy. ASRs in U1-Mel or HEp-2 cells were blocked by cycloheximide or actinomycin D. Increases in cyclins A and D1 mRNAs were noted in primed compared to unirradiated U1-Mel and HEp-2 cells; however, only cyclin A protein levels increased. Cyclin D1 and proliferating cell nuclear antigen (PCNA) protein levels were constitutively elevated in HEp-2 and U1-Mel cells, compared to the other human normal and neoplastic cells examined, and were not altered by low or high doses of radiation. Low dose primed U1-Mel cells entered S-phase 4-6 h faster than unprimed U1-Mel cells upon low-density replating. Similar responses in terms of survival recovery, transcript and prot...Continue Reading

References

Nov 1, 1978·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J FriedB D Clarkson
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·N FukunagaD A Boothman
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D M GadboisE M Bradbury
Jan 1, 1991·Annual Review of Cell Biology·S L Forsburg, P Nurse
Jan 1, 1989·Genome Génome / Conseil National De Recherches Canada·P C Hanawalt
Aug 11, 1989·Science·S Wolff
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J M GudasA B Pardee
Mar 1, 1989·Mutation Research·A Bosi, G Olivieri
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·A B Pardee
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A BoothmanS W Lee
Oct 3, 2009·NeuroImage·Mariann R WeierichLisa Feldman Barrett

❮ Previous
Next ❯

Citations

Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Octávia Monteiro GilJosé Rueff
Aug 3, 2004·Journal of Biosciences·Ashu Bhan Tiku, R K Kale
Jan 30, 2013·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Hui Yu
May 30, 1998·Biochemical Pharmacology·C Stecca, G B Gerber
Apr 24, 1999·Biochimie·F Eckardt-Schupp, C Klaus
Apr 10, 1999·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·L E FeinendegenK I Altman
Aug 6, 2002·Mutation Research·Karen J SorensenJames D Tucker
Aug 24, 2012·Cancer Research·Siwanon JirawatnotaiPiotr Sicinski
Jul 28, 2013·Cell Division·Katie R HagenHarold I Saavedra
Mar 31, 1998·Environmental Health Perspectives·E OdegaardD A Boothman
Apr 29, 2005·Uchū Seibutsu Kagaku·Hideki MatsumotoTakeo Ohnishi
Apr 16, 2008·International Journal of Radiation Oncology, Biology, Physics·Akihisa TakahashiTakeo Ohnishi
May 13, 2006·International Journal of Radiation Oncology, Biology, Physics·Sandhya XavierPeter C Brooks
Jul 16, 2005·International Journal of Radiation Biology·I Szumiel
Jul 1, 2004·Nonlinearity in Biology, Toxicology, Medicine·Ludwig E FeinendegenCharles A Sondhaus
Aug 24, 1999·Human & Experimental Toxicology·T Ikushima
Oct 1, 2004·Nonlinearity in Biology, Toxicology, Medicine·H SchöllnbergerW Hofmann
Jan 5, 2002·Radiation Research·Rashi Iyer, Bruce E Lehnert
Mar 26, 2019·Health Physics·Julie E Leblanc, Julie J Burtt
Jan 9, 2004·Acta Biologica Hungarica·Lisette M MaicoT D Smith
Jul 8, 2009·Radiation Research·Anna SanninoMaria Rosaria Scarfì
Apr 7, 2012·Anais Brasileiros De Dermatologia·Renata Aparecida Martinez Antunes Ribeiro VieiraSilvio Alencar Marques
Aug 11, 2018·Dose-response : a Publication of International Hormesis Society·Clément DevicNicolas Foray
Jul 1, 2018·International Journal of Particle Therapy·Akihisa TakahashiYukari Yoshida
Oct 2, 1998·Human & Experimental Toxicology·D A BoothmanM S Mendonca
Oct 26, 2001·Seminars in Radiation Oncology·K S LeskovD A Boothman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.